Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]
This document reports results from a Phase 1/2 clinical trial evaluating fludarabine, rituximab, and lenalidomide in minimally treated or un…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 study evaluating Rituximab (MabThera) in chronic lymphocytic leukemia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease [Phase 1]
Phase 1 trial results for obinutuzumab in Chinese participants with CD20+ malignant disease. Diseases studied include chronic lymphocytic le…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1]
A completed Phase 1 safety study evaluating CC-292 in combination with Rituximab in patients with chronic lymphocytic leukemia and/or small …
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia. [Phase 2]
Phase 2 study evaluating Rituximab (MabThera) plus chlorambucil in participants with chronic lymphocytic leukemia; the trial completed and r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating SAR245409 in combination with rituximab or bendamustine plus rituximab in patients with indolent non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating the efficacy and safety of SyB L-0501 in patients with Chronic Lymphocytic Leukemia has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Intensified Rituimab Prephase Before FCR in Untreated B-CLL [Phase 2]
A phase 2 trial of intensified rituximab prephase before FCR therapy in untreated chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of POL6326 for mobilization and transplant in hematologic malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer [Phase 2]
Phase 2 trial update of Basiliximab to prevent graft-versus-host disease after nonmyeloablative allogeneic transplantation in blood cancers;…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia [Phase 1]
Phase 1 study of Terameprocol (EM-1421) in leukemia was terminated; no efficacy results were reported in this update.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide [Phase 1]
Phase 1 trial evaluating a combination of autologous IL-2, CD40 ligand-expressing tumor cells, and lenalidomide for B-cell chronic lymphocyt…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating rituximab and alemtuzumab in older patients with progressive chronic lymphocytic leukemia; study terminated with po…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) [Phase 2]
A Phase I/II trial of the gold compound auranofin in chronic lymphocytic leukemia and related lymphoid conditions has completed its Phase 2 …
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Pneumococcal Vaccine in Untreated CLL Patients [Phase 3]
A Phase 3 clinical trial assessing a pneumococcal vaccine in patients with untreated chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 trial evaluating the combination of ofatumumab and bendamustine in patients with previously treated chronic lymphocytic leukemia and…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial comparing subcutaneous versus intravenous rituximab in combination with chemotherapy for chronic lymphocytic leukemia has comp…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab [Phase 2]
A Phase 2 clinical trial evaluating treatment for chronic lymphocytic leukemia in patients who had previously received Rituximab, with resul…
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of SG2000 for advanced chronic lymphocytic leukemia and acute myeloid leukemia has been terminated…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
A Phase 2 trial evaluating the combination of ofatumumab and high-dose methylprednisolone in patients with chronic lymphocytic leukemia has …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]
Phase 2 study update for Memgen's Ad-ISF35 cancer vaccine in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma; the trial was term…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
This is a Phase 1 clinical trial update reporting results for Cyclophosphamide, Alvocidib, and Rituximab in high-risk B-cell chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia [Phase 1]
Phase 1 trial of Alvespimycin hydrochloride in relapsed/refractory B-cell chronic lymphocytic leukemia, prolymphocytic leukemia, and small l…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 trial evaluating the combination of FCR (fludarabine, cyclophosphamide, rituximab) with bevacizumab in relapsed chronic lymphocytic …